We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > septic shock

News List

Noxopharm Files Septic Shock Treatment Patent for Veyonda® americanpharmaceuticalreview
April 15, 2021
Australian clinical-stage drug development company Noxopharm Limited announced an international patent application aimed at protecting the use of experimental anti-cancer drug, Veyonda® (idronoxil), in blocking the development of septic shock ...
Vivacelle Bio Receives Award from Navy for VBI-S Trial for Hypovolemia of Septic Shock Due to COVID americanpharmaceuticalreview
December 10, 2020
Vivacelle Bio announces the Department of Defense awarded $5.3 million dollars for the clinical trial of VBI-S, an intravenously injected fluid based upon Vivacelle Bio's phospholipid nanoparticle technology for the treatment of septic shock due to ...